Palliative treatment of unresectable pancreatico-biliary cancer by either Gemcitabine or Octreotide/Imatinib – impact on biomarkers of angiogenesis - Treiber, G; Wex, T; Malfertheiner, P (Zeitschrift für Gastroenterologie, 2007)